BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28837538)

  • 1. Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin.
    Barrett CD; Moore HB; Banerjee A; Silliman CC; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1053-1061. PubMed ID: 28837538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.
    Lawson MA; Holle LA; Dow NE; Hennig G; de Laat B; Moore HB; Moore EE; Cohen MJ; Bouchard BA; Freeman K; Wolberg AS
    J Trauma Acute Care Surg; 2022 Nov; 93(5):579-587. PubMed ID: 35687811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma.
    Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E
    FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
    Dow N; Coleman JR; Moore H; Osborn ZT; Sackheim AM; Hennig G; Butenas S; Nelson MT; Moore EE; Freeman K
    J Trauma Acute Care Surg; 2020 Feb; 88(2):258-265. PubMed ID: 31999655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
    Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
    Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.
    Moore HB; Moore EE; Huebner BR; Dzieciatkowska M; Stettler GR; Nunns GR; Lawson PJ; Ghasabyan A; Chandler J; Banerjee A; Silliman C; Sauaia A; Hansen KC
    J Trauma Acute Care Surg; 2017 Dec; 83(6):1014-1022. PubMed ID: 29190254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
    Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
    J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.
    Morton AP; Hadley JB; Ghasabyan A; Kelher MR; Moore EE; Bevers S; Dzieciatkowska M; Hansen KC; Cohen MS; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2022 Jan; 92(1):159-166. PubMed ID: 34538821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients.
    Chapman MP; Moore EE; Moore HB; Gonzalez E; Gamboni F; Chandler JG; Mitra S; Ghasabyan A; Chin TL; Sauaia A; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2016 Jan; 80(1):16-23; discussion 23-5. PubMed ID: 26491796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.
    Moore EE; Moore HB; Gonzalez E; Sauaia A; Banerjee A; Silliman CC
    Transfusion; 2016 Apr; 56 Suppl 2(Suppl 2):S110-4. PubMed ID: 27100746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant tissue-type plasminogen activator-evoked hyperfibrinolysis is enhanced by acidosis and inhibited by hypothermia but still can be blocked by tranexamic acid.
    Dirkmann D; Radü-Berlemann J; Görlinger K; Peters J
    J Trauma Acute Care Surg; 2013 Feb; 74(2):482-8. PubMed ID: 23354242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis.
    Wu K; Urano T; Ihara H; Takada Y; Fujie M; Shikimori M; Hashimoto K; Takada A
    Blood; 1995 Aug; 86(3):1056-61. PubMed ID: 7620159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock.
    Moore HB; Moore EE; Lawson PJ; Gonzalez E; Fragoso M; Morton AP; Gamboni F; Chapman MP; Sauaia A; Banerjee A; Silliman CC
    Surgery; 2015 Aug; 158(2):386-92. PubMed ID: 25979440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mechanism to enhance tPA-induced fibrinolysis: effect of limited proteolysis of PAI-1 by neutrophil elastase.
    Urano T; Wu K; Ihara H; Takada Y; Takada A
    Pol J Pharmacol; 1996; 48(2):209-13. PubMed ID: 9112653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
    Hayakawa M; Sawamura A; Gando S; Jesmin S; Naito S; Ieko M
    Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry.
    Gomez-Builes JC; Acuna SA; Nascimento B; Madotto F; Rizoli SB
    Anesth Analg; 2018 Oct; 127(4):840-849. PubMed ID: 29683829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model.
    Kostousov V; Wang YW; Cotton BA; Wade CE; Holcomb JB; Matijevic N
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):489-97. PubMed ID: 23406662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.